Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1968 Oct;47(10):2239–2252. doi: 10.1172/JCI105909

The metabolic fate of vitamin D3-3H in chronic renal failure

Louis V Avioli 1, Stanley Birge 1, Sook Won Lee 1, Eduardo Slatopolsky 1
PMCID: PMC297388  PMID: 4300189

Abstract

The absorption and metabolism of vitamin D3-3H was studied in eight patients with chronic renal failure. Although the intestinal absorption of vitamin D3-3H was normal, the metabolic fate of the vitamin was abnormal as characterized by a twofold increase in fractional turnover rate, an abnormal accumulation of biologically inactive lipid-soluble metabolites, and the urinary excretion of both vitamin D3-3H and biologically inactive metabolites. Neither alterations in water-soluble vitamin D3 metabolites nor qualitative abnormalities in protein-binding of vitamin D3 were observed in the uremic subjects. Although hemodialysis proved ineffectual in reversing the observed abnormalities in vitamin D3 metabolism and excretion, renal homotransplantation was completely successful in this regard. These experiments support the conclusion that the resistance to therapeutic doses of vitamin D often seen in patients with chronic renal failure and renal osteodystrophy results from an acquired defect in the metabolism and excretion of vitamin D.

Full text

PDF
2239

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Avioli L. V., Lee S. W., McDonald J. E., Lund J., DeLuca H. F. Metabolism of vitamin D3-3H in human subjects: distribution in blood, bile, feces, and urine. J Clin Invest. 1967 Jun;46(6):983–992. doi: 10.1172/JCI105605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Avioli L. V., Williams T. F., Lund J., DeLuca H. F. Metabolism of vitamin D3-3H in vitamin D-resistant rickets and familial hypophosphatemia. J Clin Invest. 1967 Dec;46(12):1907–1915. doi: 10.1172/JCI105680. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. CHALK K. J., KODICEK E. The association of 14C-labelled vitamin D2 with rat serum proteins. Biochem J. 1961 Apr;79:1–7. doi: 10.1042/bj0790001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chen P. S., Jr, Lane K. Serum protein binding of vitamin D3. Arch Biochem Biophys. 1965 Oct;112(1):70–75. doi: 10.1016/0003-9861(65)90011-1. [DOI] [PubMed] [Google Scholar]
  5. Clayton E. M., Seligson D., Seligson H. Inhibition of protein synthesis by N-methyl-2-pyridone-5-formamidoacetic acid and other compounds isolated from uremic patients. Yale J Biol Med. 1965 Dec;38(3):273–281. [PMC free article] [PubMed] [Google Scholar]
  6. DENT C. E., HARPER C. M., PHILPOT G. R. The treatment of renal-glomerular osteodystrophy. Q J Med. 1961 Jan;30:1–31. [PubMed] [Google Scholar]
  7. DeLuca H. F. Mechanism of action and metabolic fate of vitamin D. Vitam Horm. 1967;25:315–367. doi: 10.1016/s0083-6729(08)60039-4. [DOI] [PubMed] [Google Scholar]
  8. Eschbach J. W., Jr, Funk D., Adamson J., Kuhn I., Scribner B. H., Finch C. A. Erythropoiesis in patients with renal failure undergoing chronic dialysis. N Engl J Med. 1967 Mar 23;276(12):653–658. doi: 10.1056/NEJM196703232761202. [DOI] [PubMed] [Google Scholar]
  9. FLETCHER R. F., JONES J. H., MORGAN D. B. BONE DISEASE IN CHRONIC RENAL FAILURE. Q J Med. 1963 Oct;32:321–329. [PubMed] [Google Scholar]
  10. Fishman R. A., Raskin N. H. Experimental uremic encephalopathy. Permeability and electrolyte metabolism of brain and other tissues. Arch Neurol. 1967 Jul;17(1):10–21. doi: 10.1001/archneur.1967.00470250014002. [DOI] [PubMed] [Google Scholar]
  11. HICKS J. M., YOUNG D. S., WOOTTON I. D. THE EFFECT OF URAEMIC BLOOD CONSTITUENTS ON CERTAIN CEREBRAL ENZYMES. Clin Chim Acta. 1964 Mar;9:228–235. doi: 10.1016/0009-8981(64)90099-3. [DOI] [PubMed] [Google Scholar]
  12. Hampers C. L., Soeldner J. S., Doak P. B., Merrill J. P. Effect of chronic renal failure and hemodialysis on carbohydrate metabolism. J Clin Invest. 1966 Nov;45(11):1719–1731. doi: 10.1172/JCI105478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Harrison J. F., Blainey J. D. Low molecular weight proteinuria in chronic renal disease. Clin Sci. 1967 Oct;33(2):381–390. [PubMed] [Google Scholar]
  14. Jebsen R. H., Tenckhoff H., Honet J. C. Natural history of uremic polyneuropathy and effects of dialysis. N Engl J Med. 1967 Aug 17;277(7):327–333. doi: 10.1056/NEJM196708172770702. [DOI] [PubMed] [Google Scholar]
  15. KAYE M., PRITCHARD J. E., HALPENNY G. W., LIGHT W. Bone disease in chronic renal failure with particular reference to osteosclerosis. Medicine (Baltimore) 1960 May;39:157–190. [PubMed] [Google Scholar]
  16. KESSNER D. M., EPSTEIN F. H. EFFECT OF RENAL INSUFFICIENCY ON GASTROINTESTINAL TRANSPORT OF CALCIUM. Am J Physiol. 1965 Jul;209:141–145. doi: 10.1152/ajplegacy.1965.209.1.141. [DOI] [PubMed] [Google Scholar]
  17. Kaye M., Silverman M. Calcium metabolism in chronic renal failure. J Lab Clin Med. 1965 Oct;66(4):535–548. [PubMed] [Google Scholar]
  18. Klahr S., Tripathy K., Bolanos O. Qualitative and quantitative analysis of urinary lipids in the nephrotic syndrome. J Clin Invest. 1967 Sep;46(9):1475–1481. doi: 10.1172/JCI105639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. LICHTWITZ A., de SEZE, PARLIER R., HIOCO DBORDIER P., BORDIER P. [Glomerular hypocalciuria]. Bull Mem Soc Med Hop Paris. 1960 Jan 22;76:98–119. [PubMed] [Google Scholar]
  20. MAHER J. F., FREEMAN R. B., SCHREINER G. E. HEMODIALYSIS FOR CHRONIC RENAL FAILURE. II. BIOCHEMICAL AND CLINICAL ASPECTS. Ann Intern Med. 1965 Mar;62:535–550. doi: 10.7326/0003-4819-62-3-535. [DOI] [PubMed] [Google Scholar]
  21. McCormick G. J., Shear L., Barry K. G. Alteration of hepatic protein synthesis in acute uremia. Proc Soc Exp Biol Med. 1966 May;122(1):99–102. doi: 10.3181/00379727-122-31062. [DOI] [PubMed] [Google Scholar]
  22. Nair P. P., Bucana C. Intracellular distribution of vitamin D in rat liver. Biochim Biophys Acta. 1966 Aug 24;124(2):254–259. doi: 10.1016/0304-4165(66)90187-5. [DOI] [PubMed] [Google Scholar]
  23. Neville P. F., DeLuca H. F. The synthesis of [1,2-3H]vitamin D3 and the tissue localization of a 0.25-mu-g (10 IU) dose per rat. Biochemistry. 1966 Jul;5(7):2201–2207. doi: 10.1021/bi00871a007. [DOI] [PubMed] [Google Scholar]
  24. Pendras J. P., Erickson R. V. Hemodialysis: a successful therapy for chronic uremia. Ann Intern Med. 1966 Feb;64(2):293–311. doi: 10.7326/0003-4819-64-2-293. [DOI] [PubMed] [Google Scholar]
  25. RICH C. The calcium metabolism of a patient with renal insufficiency before and after partial parathyroidectomy. Metabolism. 1957 Nov;6(6 Pt 1):574–582. [PubMed] [Google Scholar]
  26. Rikkers H., DeLuca H. F. An in vivo study of the carrier proteins of 3H-vitamins D3 and D4 in rat serum. Am J Physiol. 1967 Aug;213(2):380–386. doi: 10.1152/ajplegacy.1967.213.2.380. [DOI] [PubMed] [Google Scholar]
  27. SCHACHTER D., DOWDLE E. B., SCHENKER H. Accumulation of Ca45 by slices of the small intestine. Am J Physiol. 1960 Feb;198:275–279. doi: 10.1152/ajplegacy.1960.198.2.275. [DOI] [PubMed] [Google Scholar]
  28. SCHACHTER D., KOWARSKI S., FINKELSTEIN J. D. VITAMIN D3: DIRECT ACTION ON THE SMALL INTESTINE OF THE RAT. Science. 1964 Jan 10;143(3602):143–144. doi: 10.1126/science.143.3602.143. [DOI] [PubMed] [Google Scholar]
  29. SCHRADE W., BOHLE E., BECKER G. Uber die Ausscheidung von Lipoproteiden im Urin bei den sogenannten Albuminurien. Dtsch Arch Klin Med. 1955;202(4):415–436. [PubMed] [Google Scholar]
  30. STANBURY S. W. Azotaemic renal osteodystrophy. Br Med Bull. 1957 Jan;13(1):57–60. doi: 10.1093/oxfordjournals.bmb.a069572. [DOI] [PubMed] [Google Scholar]
  31. STANBURY S. W., LUMB G. A. Metabolic studies of renal osteodystrophy. I. Calcium, phosphorus and nitrogen metabolism in rickets, osteomalacia and hyperparathyroidism complicating chronic uremia and in the osteomalacia of the adult Fanconi syndrome. Medicine (Baltimore) 1962 Feb;41:1–34. [PubMed] [Google Scholar]
  32. STANBURY S. W., LUMB G. A., NICHOLSON W. F. Elective subtotal parathyroidectomy for renal hyperparathyroidism. Lancet. 1960 Apr 9;1(7128):793–799. doi: 10.1016/s0140-6736(60)90678-4. [DOI] [PubMed] [Google Scholar]
  33. Slatopolsky E., Elkan I. O., Weerts C., Bricker N. S. Studies on the characteristics of the control system governing sodium excretion in uremic man. J Clin Invest. 1968 Mar;47(3):521–530. doi: 10.1172/JCI105748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Stanbury S. W., Lumb G. A. Parathyroid function in chronic renal failure. A statistical survey of the plasma biochemistry in azotaemic renal osteodystrophy. Q J Med. 1966 Jan;35(137):1–23. [PubMed] [Google Scholar]
  35. Stewart J. H., Castaldi P. A. Uraemic bleeding: a reversible platelet defect corrected by dialysis. Q J Med. 1967 Jul;36(143):409–423. [PubMed] [Google Scholar]
  36. Stohs S. J., DeLuca H. F. Subcellular location of vitamin D and its metabolites in intestinal mucosa after a 10-IU dose. Biochemistry. 1967 Nov;6(11):3338–3349. doi: 10.1021/bi00863a002. [DOI] [PubMed] [Google Scholar]
  37. THOMAS W. C., Jr, MORGAN H. G., CONNOR T. B., HADDOCK L., BILLS C. E., HOWARD J. E. Studies of antiricketic activity in sera from patients with disorders of calcium metabolism and preliminary observations on the mode of transport of vitamin D in human serum. J Clin Invest. 1959 Jul;38(7):1078–1085. doi: 10.1172/JCI103884. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. de Crousaz P., Blanc B., Antener I. Vitamin D activity in normal human serum and serum proteins. Helv Odontol Acta. 1965 Oct;9(2):151–155. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES